Table of Contents

company-logo

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.

Telo Genomics Dividend Announcement

• Telo Genomics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Telo Genomics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Telo Genomics Dividend History

Telo Genomics Dividend Yield

Telo Genomics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Telo Genomics stock? Use our calculator to estimate your expected dividend yield:

Telo Genomics Financial Ratios

P/E ratio-2.71
PEG ratio-0.04
P/B ratio13.40
ROE-185.61%
Payout ratio0.00%
Current ratio3.13
Quick ratio3.13
Cash Ratio2.69

Telo Genomics Dividend FAQ

Does Telo Genomics stock pay dividends?
Telo Genomics does not currently pay dividends to its shareholders.
Has Telo Genomics ever paid a dividend?
No, Telo Genomics has no a history of paying dividends to its shareholders. Telo Genomics is not known for its dividend payments.
Why doesn't Telo Genomics pay dividends?
There are several potential reasons why Telo Genomics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Telo Genomics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Telo Genomics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Telo Genomics a dividend aristocrat?
Telo Genomics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Telo Genomics a dividend king?
Telo Genomics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Telo Genomics a dividend stock?
No, Telo Genomics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Telo Genomics stocks?
To buy Telo Genomics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Telo Genomics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.